New research, led by the University of Southampton, has demonstrated that a nanoscale device, called a memristor, could be the ‘missing link’ in the development of implants that use electrical signals from the brain to help treat medical conditions.
Monitoring neuronal cell activity is fundamental to neuroscience and the development of neuroprosthetics – biomedically engineered devices that are driven by neural activity. However, a persistent problem is the device being able to process the neural data in real-time, which imposes restrictive requirements on bandwidth, energy and computation capacity.
In a new study, published in Nature Communications, the researchers showed that memristors could provide real-time processing of neuronal signals (spiking events) leading to efficient data compression and the potential to develop more precise and affordable neuroprosthetics and bioelectronic medicines.
Memristors are electrical components that limit or regulate the flow of electrical current in a circuit and can remember the amount of charge that was flowing through it and retain the data, even when the power is turned off.
Lead author Isha Gupta, Postgraduate Research Student at the University of Southampton, said: “Our work can significantly contribute towards further enhancing the understanding of neuroscience, developing neuroprosthetics and bio-electronic medicines by building tools essential for interpreting the big data in a more effective way.”
The research team developed a nanoscale Memristive Integrating Sensor (MIS) into which they fed a series of voltage-time samples, which replicated neuronal electrical activity.
Acting like synapses in the brain, the metal-oxide MIS was able to encode and compress (up to 200 times) neuronal spiking activity recorded by multi-electrode arrays. Besides addressing the bandwidth constraints, this approach was also very power efficient – the power needed per recording channel was up to 100 times less when compared to current best practice.
Co-author Dr Themis Prodromakis, Reader in Nanoelectronics and EPSRC Fellow in Electronics and Computer Science at the University of Southampton said: “We are thrilled that we succeeded in demonstrating that these emerging nanoscale devices, despite being rather simple in architecture, possess ultra-rich dynamics that can be harnessed beyond the obvious memory applications to address the fundamental constraints in bandwidth and power that currently prohibit scaling neural interfaces beyond 1,000 recording channels.”
The Latest on: Bioelectronic medicines
via Google News
The Latest on: Bioelectronic medicines
- Electricity is creating new hope in medicine on December 18, 2018 at 4:29 am
A century later, the idea of an artificial cardiac pacemaker was first mooted. Bioelectronic medicine gives us the power to take control of the body. Upliftconnect Photo Today bioelectronics is a high... […]
- EVFM Powered Up, AXON Gets A Boost, ARVN On Watch on December 17, 2018 at 4:17 pm
electroCore is a commercial-stage bioelectronic medicine company. Gained 17.81% to close Monday's (Dec.17) trading at $4.96. -- On November 28, the Company received FDA clearance for an expanded ... […]
- Introduction to Bioelectronic Medicine on December 11, 2018 at 3:43 am
Since the invention of the implantable pacemaker in the 1960s, doctors have been implanting devices that treat diseases and health conditions using electrical stimulation. While many bioelectronic med... […]
- Kenneth Londoner: BioSig Technologies Keeps Pace with EP Advances on December 11, 2018 at 2:59 am
We want to focus our attention on and raise awareness of the growing field of bioelectronic medicine. Through targeted use of electrical stimulation, bioelectronic therapies use the body's own ... […]
- NIH $1.4M grant supports study into precision bioelectronic medicine on November 15, 2018 at 9:28 am
Study uses endoscopy technologies to place bioelectronic medicine devices closer to organs without surgery MANHASSET, N.Y., Nov. 15, 2018 /PRNewswire/ -- Feinstein Institute for Medical Research Profe... […]
- SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for Treatment of Rheumatoid Arthritis (RA) on October 23, 2018 at 5:01 am
Oct. 23, 2018 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced long-term, 24-month follow up da... […]
- Bioelectronic medicine treatment effective for lupus, pilot clinical trial shows on October 21, 2018 at 3:37 am
A bioelectronic medicine device was effective in reducing pain and fatigue in patients with lupus, according to Feinstein Institute for Medical Research Professor Cynthia Aranow, MD, who will present ... […]
- Bioelectronic medicine treatment effective for lupus, pilot clinical trial shows on October 19, 2018 at 5:00 pm
CHICAGO, Oct. 20, 2018 /PRNewswire/ -- A bioelectronic medicine device was effective in reducing pain and fatigue in patients with lupus, according to Feinstein Institute for Medical Research Professo... […]
- First example of a bioelectronic medicine on October 9, 2018 at 11:39 am
Researchers have developed the first example of a bioelectronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves healing of a damaged nerve. Their de... […]
via Bing News